Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection

doi:10.3748/wjg.v12.i18.2876

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2928)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

369

HTML

2328

Figures (1-2)

106

Tables (1-2)

125

Sum=2928

May 14, 2006 (publication date) through Apr 16, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. May 14, 2006; 12(18): 2876-2883
Published online May 14, 2006. doi: 10.3748/wjg.v12.i18.2876

Full Size Figure Download Figure

Figure 2 Potent immune modulatory capacity of HBsAg-pulsed DCs in HBV transgenic mice. HBV transgenic mice expressed HBsAg in the sera but not anti-HBs. After two injections of HBsAg-pulsed DCs, these mice became negative for HBsAg in the sera.

Citation: Akbar SMF, Horiike N, Onji M. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection. World J Gastroenterol 2006; 12(18): 2876-2883
URL: https://www.wjgnet.com/1007-9327/full/v12/i18/2876.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i18.2876